Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56,222,082
-
Number of holders
-
441
-
Total 13F shares, excl. options
-
54,662,151
-
Shares change
-
+833,618
-
Total reported value, excl. options
-
$7,739,525,912
-
Value change
-
+$95,572,264
-
Put/Call ratio
-
87%
-
Number of buys
-
218
-
Number of sells
-
-214
-
Price
-
$141.46
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q2 2023
522 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q2 2023.
REPLIGEN CORP - COMMON STOCK (RGEN) has 441 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54,662,151 shares
of 56,222,082 outstanding shares and own 97% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7,791,077 shares), VANGUARD GROUP INC (5,056,398 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,716,765 shares), FMR LLC (2,466,191 shares), STATE STREET CORP (1,651,310 shares), SANDS CAPITAL MANAGEMENT, LLC (1,594,179 shares), BROWN CAPITAL MANAGEMENT LLC (1,445,213 shares), Artisan Partners Limited Partnership (1,399,066 shares), WELLINGTON MANAGEMENT GROUP LLP (1,367,395 shares), and AMERIPRISE FINANCIAL INC (1,273,141 shares).
This table shows the top 441 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.